DavidG.MillerMD

PubMed

• Characteristics and Risks of Endophthalmitis after 25-gauge Vitrectomy Surgery over a 14-year Period.
  Chase W Miller, Anja Rabljenovic, Cassie Papproth, Harrison Sciulli Md, Sean Platt Md
  Ophthalmology. Retina. 2024-11-30
• 1 citations
  Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes.
  Marwan Abdulaal, Richard Donkor, Jacobi Robertson, Shawn Lewis, David G Miller
  Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2024-10-01
• 4 citations
  Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab.
  Ryan Zubricky, Jasmyne McCoy, Richard Donkor, David G Miller, Nina Sonbolian
  Ophthalmology and Therapy. 2023-10-01

Journal Articles

• The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.  
  Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa M, Harrington MW, Invest Ophthalmol Vis Sci
• Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization.  
  Martidis A, Miller DG, Ciulla RP, Moorthy RS, Journal of Ocular Pharmacology and Therapeutics
• The natural history of choroidal neovascularization in high myopia.  
  Miller DG, Singerman LJ, Current Opinion in Ophthalmology
• Diabetic retinopathy and DME drug trials advance.  
  Singerman LJ, Miller DG, Rev Ophthalmol
• Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis ...  
  D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, Robertson SM, Russell S, Singerman L, Slakter JS, Sullivan EK, Yannuzzi L, Zilliox P, Retina
• Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.  
  D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger DS, Luna SP, Robertson SM, Russell S, Singerman L, Slakter JS, Yannuzzi L, Zilliox P, Ophthalmology
• Pharmacological treatments for AMD.  
  Singerman LJ, Miller DG, Rev Ophthalmol
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical ...  
  Azab M, Benchaboune M, Blinder KJ, et al, Retina
• Pegaptanib for neovascular age-related macular degeneration.  
  Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, N Engl J Med
• Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis.  
  Gonzales CR, Retina
• Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degen...  
  Maguire M, Ophthalmology
• Diabetic macular edema: what is focal and what is diffuse?  
  Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU, Am J Ophthalmol
• Surgical management of macular hole.  
  Miller DG, Lou PL, Kroll AJ, Ryan EA, International Ophthalmology Clinics
• Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic ...  
  Scott IU, Bressler NM, Bressler SB, Browning DJ, Chan CK, Danis RP, Davis MD, Kollman C, Qin H, Retina
• A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.  
  Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M, Singerman LJ, Stockdale CR, Ophthalmology
• Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.  
  Apte RS, Modi M, Masonson H, Patel M, Whitfield L, Ophthalmology
• Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.  
  Adamis AP, Ophthalmology
• The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials.  
  Bhavsar AR, Ip MS, Glassman AR, Am J Ophthalmol
• Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.  
  Russell SR, Hudson HL, Jerdan JA, Surv Ophthalmol
• Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema.  
  Danis RP, Glassman AR, Aiello LP, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, Kinyoun JL, Murtha TJ, Topping TM, Shami M, Sharuk GS, Wells JA, Arch Ophthalmol
• Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.  
  Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Patel M, Ophthalmology
• Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.  
  D'Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET Jr, Guyer DR, Katz B, Ophthalmology
• Ranibizumab versus verteporfin for neovascular age-related macular degeneration.  
  Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, N Engl J Med
• Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings.  
  Brucker AJ, Qin H, Antoszyk AN, Beck RW, Bressler NM, Browning DJ, Elman MJ, Glassman AR, Gross JG, Kollman C, Wells JA, Arch Ophthalmol
• Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables.  
  Browning DJ, Apte RS, Bressler SB, Chalam KV, Danis RP, Davis MD, Kollman C, Qin H, Sadda S, Scott IU, Retina
• Join now to see all

Books/Book Chapters

• Retinal and Vitreoretinal Surgery: Mastering the Latest Techniques. 
  Chapter: Laser treatment of age-related macular degeneration 
  Page 250 - 261Miller DG, Sharma MC, Singerman LJEditors: Boyd BF, Boyd S.Highlights of Ophthalmology Press, Panama
• Clinical Pathways in Vitreoretinal Disease. 
  Chapter: Key questions for a focused history 
  Page 3 - 12Miller DG, Singerman LJEditors: Steidl SM, Hartnett ME.Thieme, New York
• Retinal and Vitreoretinal Surgery: Mastering the Latest Techniques. 
  Chapter: Laser treatment of age-related macular degeneration 
  Page 249 - 261Miller DG, Singerman LJEditors: Boyd BF, Boyd S.Panama, Highlights of Ophthalmology Press
• Vitreo-Retinal and Uveitis Update. Proceedings of the New Orleans Academy of Ophthalmology Symposium. 
  Chapter: Diabetic retinopathy: medical considerations 
  Page 239 - 244Miller DG, Singerman LJEditors: Saer JB.Kugler Publications, The Hague
• Join now to see all

Abstracts/Posters

• Results of surgical management of senile macular holes by 25- gauge trans-conjunctival sutureless vitrectomy.
  Brown CC, Miller DG, Vision and Ophthalmology Annual Meeting
• An open label study for the evaluation of tolerability of five dose levels of intravitreous VEGF siRNA (Cand5) in patients with wet age-related macular degeneration.
  Prenner JL, Thompson JT, Miller DG, Saran BR, Gordon JF, Brucker AJ, Reich SJ, American Academy of Ophthalmology Annual Meeting
• Results of the surgical management of idiopathic epiretinal membrane.
  Sharma MC, Miller DG, Zakov ZN, Pendergast SD, Novak MA, Zegarra H, Singerman LJ, American Academy of Ophthalmology Annual Meeting
• Intravitreal triamcinolone acetonide injection for refractory pseudophakic cystoid macular edema.
  Spinak DJ, Martidis A, Miller DG, American Academy of Ophthalmology Annual Meeting
• Intravitreal triamcinolone injection for the treatment of macular edema secondary to branch retinal vein occlusion.
  Blade KA, Martidis A, Nelson ML, Belmont JB, Miller DG, Ansari I, Sivalingam A, Retina Congress
• Join now to see all